- Hem
- Om universitetet
- Hitta person
- Kalle Johansson
Kalle Johansson
Om Kalle Johansson
Doktorand i forskargruppen för "Neuroinflammation och neurodegeneration" med Markus Axelsson som huvudhandledare.
-
Non-physiological potassium concentrations in commercial culture media trigger acute seizure-like activity in human iPSC-derived
neurons
Tim Lyckenvik, Julia Izsak, Erik Arthursson, My Forsberg, Kalle Johansson, Henrik Zetterberg, Markus Axelsson, Pontus Wasling, Eric Hanse, Stephan Theiss, Sebastian Illes
SCIENTIFIC REPORTS - 2026 -
The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life
use.
Magnus Johnsson, Kajsa Eriksson, Igal Rosenstein, Lenka Nováková Nyrén, Clas Malmeström, Jan Lycke, Sofia Sandgren, Henrik Zetterberg, Kaj Blennow, Kalle Johansson, Markus Axelsson
Multiple Sclerosis and Related Disorders - 2025 -
Ion concentrations in CSF and serum are differentially and precisely
regulated
Tim Lyckenvik, My Forsberg, Kalle Johansson, Markus Axelsson, Henrik Zetterberg, Kaj Blennow, Sebastian Illes, Pontus Wasling, Eric Hanse
BRAIN COMMUNICATIONS - 2025 -
Cerebrospinal Fluid Biomarkers in Opioid Dependence: Evidence of Neuroimmune Activation and Ion Composition Changes, Without Alteration in
Orexin-A
Tim Lyckenvik, Malin Woock, Kalle Johansson, Markus Axelsson, Henrik Zetterberg, Kaj Blennow, Eric Hanse, Pontus Wasling
ADDICTION BIOLOGY - 2025 -
Cerebrospinal fluid amyloid precursor protein as a potential biomarker of fatigue in multiple sclerosis: A pilot
study
Kalle Johansson, Pontus Wasling, Lenka Novakova, S. Sjodin, Ann Brinkmalm, Gunnar Brinkmalm, Kaj Blennow, Henrik Zetterberg, Markus Axelsson
Multiple Sclerosis and Related Disorders - 2022 -
Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus
narcolepsy
Kalle Johansson, Pontus Wasling, Markus Axelsson
Acta Neurologica Scandinavica - 2021